Showing results (221-230 of 234) with videos related to
Sort By:
Pageof 24
Biorxiv : the Preprint Server for Biology|September 2, 2025
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.Molecular Cancer Therapeutics|April 21, 2026
CerS2 is a druggable target in triple-negative breast cancerHissah Alatawi, Haritha H Nair, Lingbao Ai, et al.Metabolomics : Official Journal of the Metabolomic Society|March 7, 2019
Lipidomics for wildlife disease etiology and biomarker discovery: a case study of pansteatitis outbreak in South AfricaJeremy P Koelmel, Candice Z Ulmer, Susan Fogelson, et al.Analytical Chemistry|August 19, 2020
Toward Comprehensive Per- and Polyfluoroalkyl Substances Annotation Using FluoroMatch Software and Intelligent High-Resolution Tandem Mass Spectrometry AcquisitionJeremy P Koelmel, Matthew K Paige, Juan J Aristizabal-Henao, et al.The EMBO Journal|October 17, 2018
Infiltrative and drug-resistant slow-cycling cells support metabolic heterogeneity in glioblastomaLan B Hoang-Minh, Florian A Siebzehnrubl, Changlin Yang, et al.Journal of Proteome Research|May 20, 2021
Metabolic Changes Are Associated with Melphalan Resistance in Multiple MyelomaDavid C Koomen, Mark B Meads, Dario M Magaletti, et al.Nature Communications|April 12, 2023
DAXX drives de novo lipogenesis and contributes to tumorigenesisIqbal Mahmud, Guimei Tian, Jia Wang, et al.Journal of the National Cancer Institute|August 20, 2021
Germline SUCLG2 Variants in Patients With Pheochromocytoma and ParagangliomaKaterina Hadrava Vanova, Ying Pang, Linda Krobova, et al.Acta Neuropathologica Communications|December 20, 2023
miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4Menglang Yuan, Iqbal Mahmud, Keisuke Katsushima, et al.Hepatology Communications|November 23, 2021
Lipidomics and Redox Lipidomics Indicate Early Stage Alcohol-Induced Liver DamageJeremy P Koelmel, Wan Y Tan, Yang Li, et al.Pageof 24